Obesity is increasing worldwide, and this has major implications in the setting of kidney
transplantation. Patients with obesity may have limited access to transplantation and …

The obesity pandemic continues to contribute to a worsening burden of disease worldwide.
The link between obesity and diseases such as diabetes, cardiovascular disease, and …

The clinical practice guideline Management of Obesity in Kidney Transplant Candidates and
Recipients was developed to guide decision-making in caring for people with end-stage …

Novel antiobesity medications, particularly glucagon-like peptide-1 receptor agonists (GLP-
1RAs), have expanded weight loss (WL) options for kidney transplantation (KT) candidates …

Obesity is a worldwide epidemic that leads to several non-communicable illnesses,
including chronic kidney disease (CKD). Diet and lifestyle modifications have shown a …

Purpose Severe obesity can increase risk of complications after kidney transplantation.
There is a paucity of literature on bariatric surgery outcomes in renal transplant candidates …

Heart failure (HF) and chronic kidney disease (CKD) are often associated in type 2 diabetes
(T2D), aggravate each other and exert synergistic effects to increase the risk of cardiac and …

Background Bariatric surgery has been suggested as a treatment for obesity and end-stage
renal disease (ESRD). Although the number of bariatric surgeries in patients with ESRD is …

Obesity is a growing issue that is spreading worldwide; its prevalence is ever increasing in
patients with end-stage renal disease and represents a potential barrier to transplantation …

Patients with end-stage kidney disease (ESKD) have a high prevalence of cardiovascular
disease; it is the leading cause of death in these patients and the optimisation of their …